Acquired STAT4 deficiency as a consequence of cancer chemotherapy.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3234667)

Published in Blood on October 13, 2011

Authors

Ivan P Lupov1, Larry Voiles, Ling Han, Allysia Schwartz, Manuel De La Rosa, Kinnari Oza, David Pelloso, Ravi P Sahu, Jeffrey B Travers, Michael J Robertson, Hua-Chen Chang

Author Affiliations

1: Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN 46202, USA.

Articles cited by this

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 6.23

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. Lancet (2010) 5.59

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (1996) 5.45

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science (1994) 3.71

Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc Natl Acad Sci U S A (1994) 2.81

Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol (1996) 2.68

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68

Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A (1995) 2.52

GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity (2003) 2.30

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med (1994) 2.29

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study. Ann Oncol (2008) 2.23

Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol (1994) 1.98

PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity (2005) 1.93

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol (2000) 1.82

SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity (2005) 1.64

Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood (2000) 1.60

Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science (2010) 1.53

Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses. EMBO J (2003) 1.39

Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood (2007) 1.32

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood (1996) 1.17

Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment. Oncologist (1996) 1.13

STAT4 expression in human T cells is regulated by DNA methylation but not by promoter polymorphism. J Immunol (2005) 1.09

Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood (2009) 1.07

Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J Immunother Emphasis Tumor Immunol (1995) 1.01

IFN-gamma-induced apoptosis and microbicidal activity in monocytes harboring the intracellular bacterium Coxiella burnetii require membrane TNF and homotypic cell adherence. J Immunol (2002) 1.00

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies. Clin Cancer Res (2002) 0.99

IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. J Immunol (1999) 0.98

Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Blood (2005) 0.97

IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Oncogene (2004) 0.95

Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. Blood (2001) 0.95

Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells. Blood (2006) 0.94

Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Clin Cancer Res (2003) 0.87

MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation. Mol Immunol (2007) 0.82

Metallothionein mRNA stability in chicken and mouse cells. Biochim Biophys Acta (1991) 0.76

Articles by these authors

Trajectories of disability in the last year of life. N Engl J Med (2010) 5.55

Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol (2007) 5.16

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma. J Clin Oncol (2006) 4.87

Transitions between frailty states among community-living older persons. Arch Intern Med (2006) 4.38

The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol (2010) 3.97

Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41

Bathing disability and the risk of long-term admission to a nursing home. J Gerontol A Biol Sci Med Sci (2006) 2.73

T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood (2006) 2.34

Risk factors and precipitants of long-term disability in community mobility: a cohort study of older persons. Ann Intern Med (2012) 2.27

Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol (2003) 2.21

A fungal-responsive MAPK cascade regulates phytoalexin biosynthesis in Arabidopsis. Proc Natl Acad Sci U S A (2008) 2.13

Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis (2004) 2.06

Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination. Immunity (2008) 2.04

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. Lancet Oncol (2012) 1.95

Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis. Leuk Lymphoma (2006) 1.89

Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats. Nature (2008) 1.85

The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med (2003) 1.82

The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc (2004) 1.72

The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc (2003) 1.66

Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. J Immunol (2007) 1.56

Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature (2013) 1.56

p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood (2009) 1.53

(E)-N'-(5-Chloro-2-hydroxy-benzyl-idene)-3,5-dihydroxy-benzohydrazide mono-hydrate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.51

IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol (2009) 1.51

IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol (2010) 1.49

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma. J Clin Oncol (2009) 1.46

In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis (2008) 1.44

Dual-level regulation of ACC synthase activity by MPK3/MPK6 cascade and its downstream WRKY transcription factor during ethylene induction in Arabidopsis. PLoS Genet (2012) 1.39

Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol (2002) 1.39

Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. J Gen Intern Med (2006) 1.35

Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30

UVB-induced senescence in human keratinocytes requires a functional insulin-like growth factor-1 receptor and p53. Mol Biol Cell (2008) 1.26

Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther (2003) 1.25

PU.1 regulates TCR expression by modulating GATA-3 activity. J Immunol (2009) 1.20

Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species. J Immunol (2009) 1.19

Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc (2007) 1.18

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev (2013) 1.17

Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells. Immunology (2009) 1.16

Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J Biol Chem (2005) 1.16

The relationship between intervening hospitalizations and transitions between frailty states. J Gerontol A Biol Sci Med Sci (2011) 1.15

Improved Peptide and Protein Torsional Energetics with the OPLSAA Force Field. J Chem Theory Comput (2015) 1.13

STAT4 is required for interleukin-12-induced chromatin remodeling of the CD25 locus. J Biol Chem (2003) 1.12

The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp Hematol (2006) 1.12

UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system. J Invest Dermatol (2008) 1.11

Scratching the surface: towards understanding the pathogenesis of atopic dermatitis. Crit Rev Immunol (2008) 1.10

Impaired development of human Th1 cells in patients with deficient expression of STAT4. Blood (2009) 1.07

Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects. Prostaglandins Other Lipid Mediat (2008) 1.06

OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome. Hum Mol Genet (2012) 1.06

Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell Immunol (2007) 1.05

Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease. Clin Cancer Res (2004) 1.05

The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis (2012) 1.05

Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3. PLoS One (2011) 1.02

MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1. J Cell Biochem (2014) 1.02

Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol (2002) 1.01

Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J Immunol (2004) 1.00

Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells. Mol Cancer Ther (2010) 1.00

A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol (2008) 1.00

Functional trajectories in older persons admitted to a nursing home with disability after an acute hospitalization. J Am Geriatr Soc (2008) 0.99

Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons. J Interferon Cytokine Res (2008) 0.99

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies. Clin Cancer Res (2002) 0.99

Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J Immunol (2013) 0.98

Comparisons between older men and women in the trajectory and burden of disability over the course of nearly 14 years. J Am Med Dir Assoc (2013) 0.97

Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation. J Invest Dermatol (2013) 0.97

Impaired interferon-gamma production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma. Blood (2005) 0.97

Ultraviolet B radiation of human skin generates platelet-activating factor receptor agonists. Photochem Photobiol (2010) 0.96

Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood (2002) 0.96

N'-(2-Hydr-oxy-5-chloro-benzyl-idene)-4-nitro-benzohydrazide methanol solvate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.95

Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (Albany NY) (2011) 0.95

Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer (2008) 0.95

Primary pancreatic follicle center-derived lymphoma masquerading as carcinoma. Gastroenterol Hepatol (N Y) (2011) 0.95

Transcription factor-dependent chromatin remodeling of Il18r1 during Th1 and Th2 differentiation. J Immunol (2008) 0.94

Estimates of active and disabled life expectancy based on different assessment intervals. J Gerontol A Biol Sci Med Sci (2005) 0.94

Anomalous origin of the left coronary artery from the pulmonary artery in children: 15 years experience. Pediatr Cardiol (2010) 0.94

Factors associated with recovery of prehospital function among older persons admitted to a nursing home with disability after an acute hospitalization. J Gerontol A Biol Sci Med Sci (2009) 0.94

An empirical study of different diagnostic criteria for delirium among elderly medical inpatients. J Neuropsychiatry Clin Neurosci (2003) 0.93

The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem (2003) 0.93

Predisposing factors and precipitants for bathing disability in older persons. J Am Geriatr Soc (2007) 0.93

The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther (2002) 0.92

Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol (2002) 0.92

Comparison of urinary biomarkers for early detection of acute kidney injury after cardiopulmonary bypass surgery in infants and young children. Pediatr Cardiol (2012) 0.91

STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease. J Immunol (2008) 0.91

Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J Pharmacol Exp Ther (2002) 0.91

Kindlin-2 promotes genome instability in breast cancer cells. Cancer Lett (2012) 0.90

Two novel naphthalene glucosides and an anthraquinone isolated from Rumex dentatus and their antiproliferation activities in four cell lines. Molecules (2012) 0.90

Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease. J Invest Dermatol (2002) 0.90

Constitutively active STAT6 predisposes toward a lymphoproliferative disorder. Blood (2007) 0.90

Expression changes of ERK1/2, STAT3 and SHP-2 in bone marrow cells from gamma-ray induced leukemia mice. J Radiat Res (2006) 0.89

Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett (2012) 0.88

Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.88

Epidemiology of restricting back pain in community-living older persons. J Am Geriatr Soc (2011) 0.88

Triggered sampling could help improve longitudinal studies of persons with elevated mortality risk. J Clin Epidemiol (2006) 0.87

Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature. Medicine (Baltimore) (2015) 0.86

Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin. Cancer Immunol Immunother (2013) 0.86